Makary Resigns as FDA Commissioner
He leaves after pressure from industry, anti-abortion activists and White House allies over drug reviews, flavored vapes and abortion pill policy.
- On Tuesday, FDA Commissioner Marty Makary stepped down after 13 months leading the agency, with Kyle Diamantas expected to serve as acting commissioner following a decision by Health and Human Services Secretary Robert F. Kennedy Jr. and White House approval.
- Makary's tenure faced months of internal turmoil marked by sweeping layoffs, turnover among senior leadership, and repeated clashes with lawmakers and the pharmaceutical industry over his handling of mifepristone and flavored vapes.
- Last Tuesday, the FDA authorized fruit-flavored vapes fulfilling a 2024 campaign promise, while the Supreme Court recently allowed nationwide mifepristone access despite Republicans continuing to push for reversals of telehealth dispensing rules.
- This departure marks the administration's fourth high-profile exit this year, following Labor Secretary Lori Chavez DeRemer's April resignation and the removal since January of Homeland Security Secretary Kristi Noem and Attorney General Pam Bondi.
- Regulatory uncertainty now surrounds the FDA's enforcement priorities, as the agency has not released its review of abortion pills—a process Makary reportedly asked officials to delay until after the midterms.
189 Articles
189 Articles
Nebraska Examiner
Trump’s FDA commissioner exits after pressure from anti-abortion groups
The main entrance of the U.S. Food and Drug Administration's Building 1, which houses the commissioner’s office, in Silver Spring, Maryland. (Photo by Michael J. Ermath/FDA)WASHINGTON — U.S. Food and Drug Administration Commissioner Marty Makary on Tuesday became the latest member of President Donald Trump’s administration to leave their post this year. “I want to thank Dr. Marty Makary for having done a great job at the FDA. So much was accomp…
Did Trump Fire Marty Makary? The Mango Vape Battle That 'Helped Push' FDA Commissioner Out the Door
A bitter internal clash over mango-flavoured vapes, mounting White House frustration and intensifying political pressure appear to have ended Marty Makary's short and turbulent tenure atop America's top drug regulator. The resignation of FDA Commissioner Marty Makary has triggered speculation over whether US President Donald Trump effectively forced him out after weeks of public criticism and behind-the-scenes disputes over flavoured vaping prod…
Marty Makary's tenure as head of FDA ends with 'difficulty'
Food and Drug Administration (FDA) Commissioner Marty Makary stepped down on Tuesday, capping weeks of pressure and rumors that his job was in jeopardy. The agency’s top food regulator, Kyle Diamantas, will take over, President Trump wrote on Truth Social. Trump told reporters ahead of his trip to China on Tuesday that Makary had been “having some difficulty” in the role. ...
Coverage Details
Bias Distribution
- 58% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
